Global distribution Olerup is a global distributor of molecular diagnostic products and services for HLA typing and antibody detection, with offices in Austria and the US, recently operating as a CareDx subsidiary. This indicates potential for cross-selling CareDx technologies and expanded distribution partnerships in Europe and North America.

Acquisition leverage As a CareDx subsidiary since 2016, there is an opportunity to align sales narratives with CareDx’s broader portfolio, leveraging existing customer relationships and onboarding pathways to introduce complementary HLA typing, antibody detection, and related diagnostic solutions.

Moderate revenue range With estimated revenue between 10 to 25 million USD and a small internal team, there may be room to scale through channel partnerships, managed services, and automated sales processes that can extend reach without proportional headcount growth.

Niche market focus Specialization in HLA typing and antibody detection places Olerup in a specialized biotech segment with steady demand from transplant centers and diagnostics labs, suggesting targeted outreach to procurement and lab operations teams seeking robust, validated workflows.

Tech and analytics readiness Olerup's web tech stack and analytics footprint (cloudy hosting, analytics, and tag management) imply readiness for digital engagement, lead nurture, and data-driven marketing experiments to optimize outreach to decision-makers in transplant diagnostics and molecular testing.